BeiGene | A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

⟵ Back to Search Results

A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

Beigene Study ID

BGB-R046-101

ClinicalTrials.gov ID

NCT06487858

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Sex: All

Age: 18 Years / N/A

No Study Documents